Billionaire Teva Chairman May Retire by Year’s End
This article is for subscribers only.
Teva Pharmaceutical Industries Ltd. Chairman Phillip Frost may retire before his board term ends next year if he can deliver on pledges to overhaul governance and find an adequate successor.
“I might not want to go that far,” Frost, 77, said of his current term by telephone from Miami yesterday. “I might want to retire sooner. Practically speaking, I’m at the age where it doesn’t really make a lot of sense to go beyond that, but that might already be longer than what I want.”